{
    "xml": "<topic id=\"PHP1658\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/colesevelam-hydrochloride\" basename=\"colesevelam-hydrochloride\" title=\"COLESEVELAM HYDROCHLORIDE\">\n<title>COLESEVELAM HYDROCHLORIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1108\" namespace=\"/interactions/list-of-drug-interactions/lipid-regulating-drugs/bile-acid-sequestrants/colesevelam\">Colesevelam</xref>\n</p>\n<data name=\"vtmid\">441851004</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_591996686\" title=\"Bile acid sequestrants\">Bile acid sequestrants</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34564\" title=\"BILE ACID SEQUESTRANTS\" namespace=\"/drug-classes/bile-acid-sequestrants\">BILE ACID SEQUESTRANTS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP68241\" outputclass=\"indicationsAndDose\" rev=\"1.13\" parent=\"/drugs/colesevelam-hydrochloride\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Primary hypercholesterolaemia as an adjunct to dietary measures (monotherapy)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>3.75&#8239;g daily in 1&#8211;2 divided doses; maximum 4.375&#8239;g per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Primary hypercholesterolaemia as an adjunct to dietary measures, in combination with a statin</p>\n<p outputclass=\"therapeuticIndication\">Primary and familial hypercholesterolaemia, in combination with ezetimibe, either with or without a statin</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2.5&#8211;3.75&#8239;g daily in 1&#8211;2 divided doses, may be taken at the same time as the statin and ezetimibe.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP68801\" outputclass=\"contraindications\" rev=\"1.7\" parent=\"/drugs/colesevelam-hydrochloride\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Biliary obstruction</ph>; <ph outputclass=\"contraindication\">bowel obstruction</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71495\" outputclass=\"cautions\" rev=\"1.7\" parent=\"/drugs/colesevelam-hydrochloride\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Gastro-intestinal motility disorders</ph>; <ph outputclass=\"caution\">inflammatory bowel disease</ph>; <ph outputclass=\"caution\">major gastro-intestinal surgery</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP68076\" outputclass=\"interactions\" rev=\"1.10\" parent=\"/drugs/colesevelam-hydrochloride\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (colesevelam).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67077\" outputclass=\"sideEffects\" rev=\"1.8\" parent=\"/drugs/colesevelam-hydrochloride\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Headache</ph>; <ph outputclass=\"sideEffect\">myalgia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP68457\" outputclass=\"hepaticImpairment\" parent=\"/drugs/colesevelam-hydrochloride\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP66307\" outputclass=\"monitoringRequirements\" parent=\"/drugs/colesevelam-hydrochloride\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Patients receiving ciclosporin should have their blood-ciclosporin concentration monitored before, during, and after treatment with colesevelam.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71927\" outputclass=\"directionsForAdministration\" rev=\"1.8\" parent=\"/drugs/colesevelam-hydrochloride\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Other drugs should be taken at least 4 hours before or after colesevelam to reduce possible interference with absorption.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67662\" outputclass=\"patientAndCarerAdvice\" rev=\"1.15\" parent=\"/drugs/colesevelam-hydrochloride\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patient counselling on administration is advised for colesevelam hydrochloride tablets (avoid other drugs at same time).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1658-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/colesevelam-hydrochloride\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76693\" title=\"Tablet\" namespace=\"/drugs/colesevelam-hydrochloride/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1108\" namespace=\"/interactions/list-of-drug-interactions/lipid-regulating-drugs/bile-acid-sequestrants/colesevelam\" title=\"Colesevelam\" count=\"1\" rel=\"link\">Colesevelam</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34564\" namespace=\"/drug-classes/bile-acid-sequestrants\" title=\"BILE ACID SEQUESTRANTS\" count=\"1\" rel=\"link\">BILE ACID SEQUESTRANTS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76693\" namespace=\"/drugs/colesevelam-hydrochloride/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP1658",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/colesevelam-hydrochloride",
    "basename": "colesevelam-hydrochloride",
    "title": "COLESEVELAM HYDROCHLORIDE",
    "interactants": [
        {
            "id": "bnf_int_1108",
            "label": "Colesevelam"
        }
    ],
    "vtmid": "441851004",
    "drugClassification": [
        "Bile acid sequestrants"
    ],
    "inheritsFromClass": [
        "BILE ACID SEQUESTRANTS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Primary hypercholesterolaemia as an adjunct to dietary measures (monotherapy)",
                        "html": "Primary hypercholesterolaemia as an adjunct to dietary measures (monotherapy)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "3.75 g daily in 1&#8211;2 divided doses; maximum 4.375 g per day.",
                        "html": "<p>3.75&#8239;g daily in 1&#8211;2 divided doses; maximum 4.375&#8239;g per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Primary hypercholesterolaemia as an adjunct to dietary measures, in combination with a statin",
                        "html": "Primary hypercholesterolaemia as an adjunct to dietary measures, in combination with a statin"
                    },
                    {
                        "textContent": "Primary and familial hypercholesterolaemia, in combination with ezetimibe, either with or without a statin",
                        "html": "Primary and familial hypercholesterolaemia, in combination with ezetimibe, either with or without a statin"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "2.5&#8211;3.75 g daily in 1&#8211;2 divided doses, may be taken at the same time as the statin and ezetimibe.",
                        "html": "<p>2.5&#8211;3.75&#8239;g daily in 1&#8211;2 divided doses, may be taken at the same time as the statin and ezetimibe.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Biliary obstruction",
                "html": "Biliary obstruction"
            },
            {
                "type": "contraindications",
                "textContent": "bowel obstruction",
                "html": "bowel obstruction"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Gastro-intestinal motility disorders",
                "html": "Gastro-intestinal motility disorders"
            },
            {
                "type": "cautions",
                "textContent": "inflammatory bowel disease",
                "html": "inflammatory bowel disease"
            },
            {
                "type": "cautions",
                "textContent": "major gastro-intestinal surgery",
                "html": "major gastro-intestinal surgery"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (colesevelam).",
                "html": "<p>Appendix 1 (colesevelam).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Headache",
                        "html": "Headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "myalgia",
                        "html": "myalgia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution.",
                "html": "<p>Manufacturer advises caution.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Patients receiving ciclosporin should have their blood-ciclosporin concentration monitored before, during, and after treatment with colesevelam.",
                "html": "<p>Patients receiving ciclosporin should have their blood-ciclosporin concentration monitored before, during, and after treatment with colesevelam.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Other drugs should be taken at least 4 hours before or after colesevelam to reduce possible interference with absorption.",
                "html": "<p>Other drugs should be taken at least 4 hours before or after colesevelam to reduce possible interference with absorption.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patient counselling on administration is advised for colesevelam hydrochloride tablets (avoid other drugs at same time).",
                "html": "<p>Patient counselling on administration is advised for colesevelam hydrochloride tablets (avoid other drugs at same time).</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76693",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1108",
                "label": "Colesevelam",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34564",
                "label": "BILE ACID SEQUESTRANTS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76693",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}